Alligator Bioscience Announces Financing of Up to SEK 80 Million Extending Cash Runway to Q1 2025 [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Aptevo Therapeutics Inc. (APVO)
Last aptevo therapeutics inc. earnings: 8/9 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aptevotherapeutics.com/investor-overview
Company Research
Source: Yahoo! Finance
KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. LUND, SWEDEN / ACCESSWIRE / June 25, 2024 / The board of directors of Alligator Bioscience AB (publ) (STO:ATORX) ("Alligator" or the "Company") has today resolved on a directed issue of convertibles to Fenja Capital II A/S ("Fenja") raising gross proceeds of SEK 12 million (the "Convertibles"). Furthermore, the Company has also entered into an agreement with Fenja for a loan facility of up to SEK 68 million (the "Loan Facility" and together with the Convertibles, the "Financing"). The transaction provides Alligator with financial and strategic flexibility, with the full Financing extending the cash runway into the first quarter of 2025. Reasons and motives for the Financing The Financing consists of a first tranche of SEK 50 million, of which SEK 12 million a
Show less
Read more
Impact Snapshot
Event Time:
APVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APVO alerts
High impacting Aptevo Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
APVO
News
- Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq RulesAccesswire
- Alligator Bioscience Announces Substantial Overall Survival Benefit and Unprecedented Duration of Response in the 18-Month Analysis from Mitazalimab OPTIMIZE-1 Phase 2 Study in 1st Line Pancreatic Cancer [Yahoo! Finance]Yahoo! Finance
- Aptevo Participating in the BIO International ConventionAccesswire
- Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology [Yahoo! Finance]Yahoo! Finance
APVO
Sec Filings
- 6/28/24 - Form 424B4
- 6/26/24 - Form S-1/A
- 6/14/24 - Form S-1
- APVO's page on the SEC website